Clinical trial
Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal…
NCT00331188 · Debiovision, Industry · Completed
Key facts
| NCT number | NCT00331188 |
|---|---|
| Title | Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding |
| Official title | The Early Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Due to Portal Hypertension |
| Lead sponsor | Debiovision, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Esophageal Varices, Portal Hypertension, Gastric Varices, Esophageal Bleeding |
| Intervention type | Drug |
| Interventions | Sanvar® (vapreotide) |
| Enrollment | 70 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | May 29, 2006 |
| Last update posted | Jul 8, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: